| Dr Billa is a Professor of Pharmaceutics at the College of Pharmacy, Qatar University. He is a Pharmacist and obtained his PhD in Pharmaceutical Technology from the University of Science, Malaysia in 2000, after a brief an attachment at a Pharmaceutical Industry. He Joined the International Medical University in 2001 as a Lecturer in Pharmaceutics and the Chief Scientist of the EQUILAB Bioequivalence laboratory in the same University, where he oversaw the execution of bioequivalence studies to Pharmaceutical Industries. In 2005, He joined the School of Pharmacy, University of Nottingham, Malaysia Campus as an Assistant Professor and was promoted to Associate Professor in 2007 and to full Professor in 2015. During his 15-year engagement at the University of Nottingham, he held several administrative positions, including Associate Dean for Research & Knowledge Exchange and Deputy Head of School. Dr Billa is recipient of numerous University, National and International grants, including a Euro FP7 Bio-design collaborative research grant worth 1million euros aimed at deciphering the fate of growth factors in bone tissue engineering. He has served as a consultant to a Pharmaceutical Company and participated more than 32 bioequivalence studies on generic pharmaceuticals products to sponsors. He has published over 90 peer-reviewed journals, supervised 2 Postdoctoral candidates, 18 PhD and 15 MSc candidates as primary supervisor. He has also served as External Examiner to 23 PhD student theses. Dr Billa’s research interest is primarily aimed at improving the bioavailability of drugs via novel technologies such as nanoparticle formulation. Emphasis is on the use of natural therapeutics of plant origin, especially anticancer agents and the use of biodegradable/biocompatible excipients and oral delivery of developed nanoparticle formulations. These are typically polymeric, solid lipid and nanostructured lipid carriers (SLN & NLC). He is also interested in the application of in vitro and in vivo models in understanding the performance of nanoparticle deployment into and across epithelia. Other research interest involve the application of 3D printing technology in the development of drug delivery systems and biomedical devices. |
List
Leave a Reply